Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +3.48% |
|
-0.48% | -3.70% |
06-17 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
05-23 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 2.140 | 2.180 | 2.370 |
Spread/Res. | -2.80% | -4.59% | -12.24% |
Spread/Supp. | +6.67% | +6.67% | +6.67% |
Support | 1.950 | 1.950 | 1.950 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PMCB Stock
- Charts PharmaCyte Biotech, Inc.